Adcytherix Launches with €30 Million Seed Funding to Pioneer Next-Generation Antibody-Drug Conjugates for Cancer Treatment

Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and sold Emergence T...

June 11, 2024 | Tuesday | News
ArkeaBio™ Secures $26.5 Million Series A Funding to Develop Paradigm-Shifting Livestock Methane Reduction Vaccine

ArkeaBio™, a leading ag-biotech start-up developing a vaccine to reduce livestock methane emissions, announced the close of a $26.5 million Series A ...

May 09, 2024 | Thursday | News
German Chancellor Olaf Scholz Lauds Merck's €300 Million Investment in New Darmstadt Research Center, Bolstering Germany as a Top Biopharmaceutical Hub

German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony Research center to accelerate biop...

April 26, 2024 | Friday | News
Abzena's $5 Million Investment Boosts Bristol Facility's Bioconjugation Capabilities and Enhances Operational Efficiency

 The $5 million investment in expanded laboratory space, new equipment, and facility upgrades, builds upon the site’s existing bioconjugation ca...

March 28, 2024 | Thursday | News
Samsung Ventures Backs BrickBio to Pave the Way for Next-Generation Therapies

Samsung Ventures, a key player in the life sciences sector, has made a strategic investment in BrickBio, Inc., a preclinical-stage biopharmaceutical compan...

March 19, 2024 | Tuesday | News
Kenai Therapeutics Secures $82 Million Series A Funding to Advance Parkinson's Disease Treatment Trials

  – Proceeds will be used to complete clinical demonstration trials of the lead candidate drug RNDP-001 for the treatment of Parkinson's di...

March 11, 2024 | Monday | News
AstraZeneca plans £650 million investment in UK

AstraZeneca intends to invest £450 million to research, develop and manufacture vaccines in Speke, Liverpool, a facility which will be operationall...

March 07, 2024 | Thursday | News
BiomX Acquires Adaptive Phage Therapeutics, Secures $50M for Clinical Trials

  Immediately after the effective time of the Acquisition, and before giving effect to the concurrent private placement the former stockholders of Bi...

March 06, 2024 | Wednesday | News
Willow Biosciences Secures Second Strategic Investment from Kalsec

Willow Biosciences, a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable functional ing...

March 04, 2024 | Monday | News
FogPharma® Secures $145 Million in Series E Funding to Revolutionize Cancer Treatment with Pioneering Helicon™ Peptide Technology

FogPharma®, a clinical-stage biopharmaceutical company dedicated to delivering a new class of therapies that go beyond the limits of currently availabl...

March 04, 2024 | Monday | News
Curve Therapeutics Secures £40.5 Million Series A Funding Led by Pfizer Ventures to Propel Cancer Drug Discovery Efforts

Curve Therapeutics, a pioneering biotechnology firm, announced a significant £40.5 million Series A funding round, led by Pfizer Ventures and joined ...

February 28, 2024 | Wednesday | News
GDMC, Singaporean Advanced Therapy Manufacturer, Raises $21M to Expand Global Genetic Medicine Operations

The round also included premier investors such as WI Harper Group, a leading cross-border venture capital firm, and SEEDS Capital, the investment arm of go...

January 26, 2024 | Friday | News
DelSiTech Secures EUR 10M Funding to Advance Silica-Based Drug Delivery Platform

New investment from DRW Venture Capital LLC and Tolmar International Ltd Funds will be used to advance its proprietary, silica-based, drug delivery...

January 16, 2024 | Tuesday | News
Pfizer Urges Shareholders to Decline TRC Capital's Below-Market Mini-Tender Offer

Pfizer does not endorse TRC Capital Investment’s unsolicited mini-tender offer and recommends that stockholders do not tender their shares in respons...

January 11, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close